加入 getAbstract 阅读摘要

Chronic

加入 getAbstract 阅读摘要

Chronic

For big pharma, the perfect patient is wealthy, permanently ill and a daily pill-popper. Will medicine ever recover?

Aeon,

5 分钟阅读
5 个要点速记
音频和文本

看看什么内容？

Caution: Market forces in the drug industry can cause unpleasant side effects.

自动生成的音频
  • 0.5×
  • 0.75×
  • 1×
  • 1.25×
  • 1.5×
  • 1.75×
1×
自动生成的音频

Editorial Rating

8

Qualities

  • Eye Opening
  • Concrete Examples
  • Engaging

Recommendation

At the heart of the pharmaceutical industry lies a paradox: Devoted to helping people get well, the drug industry depends on patients staying sick. Clayton Dalton, a resident at the Massachusetts General Hospital in Boston, traces the economic forces that influence research and treatment choices for chronic disease. For anyone interested in the business of health and disease, getAbstract recommends Dalton’s analysis of the interactions of money and medicine.

Summary

Most of the world’s drug development happens in market economies, where financial incentives distort choices about where to spend research dollars. In April 2018, for example, a Goldman Sachs report advised companies in the drug and biotech industries to avoid investments in medicines that cure disease. Drug companies profit more from drugs that only control conditions, so that patients have to take the drugs for the rest of their lives. Legislation can modify financial incentives and thereby redirect investments in medical research and treatment. In one example, the 1982 Orphan...

About the Author

Clayton Dalton is a medical resident at the Massachusetts General Hospital in Boston. 

Comment on this summary